SUN-LB280: Double Blind Multicenter Phase III Gortec Trial Evaluating the Efficacy of Oral Immune Modulating Formulae Therapy During Adjuvant Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC). (September 2016) - Senesse, P.F.; Graff-Cailleaud, P.; Sire, C.; Gallocher, O.; Lavau-Denes, S.; Garcia-Ramirez, M.; Alfonsi, M.; Cupissol, D.; Kaminsky, M.-C.; Fiore, S.; Flori, N.; de Forges, H.; et al.